Juice Beauty founder Karen Behnke launched Beauty Crush Skincare, a new line built on regenerative biotechnology and grape exosomes from her certified organic Sonoma County vineyard — a signal of where clean beauty is heading next.
The Falanghina grape is a southern Italian variety, grown mostly in Campania, that predates Roman winemaking by several centuries. It survived a period in the nineteenth century when phylloxera destroyed most of Europe’s vineyards, partly because its roots ran deep in volcanic soil that was hard for the louse to reach. Karen Behnke grows it in Sonoma County, at her certified organic vineyard, and has spent four years working with biotech partners and researchers from UC Davis to extract from it something called an exosome — a submicroscopic vesicle that plants produce to carry molecular messages between cells. The resulting patent-pending formula, combined with extracts from Sagrantino grapes also grown on the property, forms the foundation of Beauty Crush Skincare, which Behnke launched direct-to-consumer on June 3. It is her fourth company, and by most measures, her most technically specific.
Behnke founded Juice Beauty in 2005, when organic skincare existed mostly in health food stores and was described, charitably, as an acquired taste — products that smelled aggressively of herbs and performed inconsistently, as though the commitment to organic certification had exhausted all available energy before the formulation could be finalized. Her argument, which turned out to be correct, was that organic ingredients and genuine efficacy were not contradictory, and that there was a meaningful market of consumers who found the phrase “paraben-free” both alarming and reassuring at the same time. Juice Beauty became a reference point in what would eventually be called clean beauty: a category organized almost entirely around its exclusions, by the long list of ingredients it refused to use, by the regulatory gap between what was permitted on U.S. shelves and what had been restricted in Europe for years. The labels told you what wasn’t there.
That was one phase. A second is now underway, and it operates from a different premise. The exclusion approach assumed that safety was the core problem — that the industry had been putting harmful things in products, and the solution was to remove them. What’s emerging now assumes that efficacy is the opportunity: that biotechnology has advanced far enough to deliver genuinely active, plant-derived ingredients at a level of precision and potency that first-generation clean beauty couldn’t access. Exosomes are one of the more legible examples of this shift. Naturally occurring in biological systems, they function as delivery mechanisms, carrying proteins, lipids, and signaling molecules between cells. The synthetic and human-derived versions have been used in clinical dermatology and wound healing for years. Plant-derived exosomes — extracted from grapes, turmeric, ginger, grapefruit — are newer to skincare, and are arriving precisely when consumers are starting to ask what the positive ingredient story is, not just what’s been excluded.
Beauty Crush launches with four products: a $68 Triple Action Exocellular Antioxidant Serum, a $68 Triple Action Exocellular Glow Moisturizer, a $36 Head-to-Toe Cleanser, and a $38 Peptide Body Moisturizer. The line is built around the Falanghina exosome complex alongside Sagrantino grape extracts and other biotech-derived actives. Clinical testing showed 100 percent of participants reporting smoother-feeling skin and 97 percent reporting a younger-looking appearance after the three-step facial routine. These are participant-reported outcomes — useful, but worth reading alongside independent efficacy data when it becomes available.
The vineyard origin matters more than it might seem; Behnke’s property carries USDA certified organic status, which means no synthetic pesticides, no GMOs, and a documented approach to soil health. But the more interesting detail is the choice of varietals. Falanghina and Sagrantino are not cosmetically familiar grapes. They are not the Chardonnay or Cabernet that anchor Sonoma’s commercial identity and appear on marketing materials from a dozen beauty brands that have discovered the phrase “wine country skincare.” Choosing them suggests a formulation decision driven by bioactive profile rather than brand recognition — the grapes were selected for what they contain, not for what they evoke.
That distinction is increasingly the line separating regenerative beauty brands with genuine research behind them from those that have learned to use the vocabulary of biotechnology without the substance. The clean beauty market in the U.S. is valued at over $10 billion and is growing steadily, which means it has also attracted a certain amount of repositioning by brands that were never particularly clean to begin with and have found that the language of plant-derived actives and regenerative science is easier to adopt than the science itself. Behnke’s track record is not a guarantee that Beauty Crush delivers everything it claims — that will take time and independent review — but it is a reason to pay close attention to the specific claims being made. She is building, at sixty-something, the fourth iteration of an argument she started in 2005: that what you put into a formula is as important as what you leave out, and that the difference is worth growing an ancient grape variety in California to prove.
Related on Ethos:
